Resmed (RSMDF) Other Accumulated Expenses (2010 - 2021)

Resmed has reported Other Accumulated Expenses for 12 years, with the latest figure at $12.3 million in Q2 2021.

• For the quarter ending Q2 2021, Other Accumulated Expenses fell 1.77% year-over-year to $12.3 million; the trailing twelve-month figure through Jun 2021 stood at $12.3 million (down 1.77% YoY), and the FY2021 full-year result was $12.3 million, down 1.77% from the prior year.
• Other Accumulated Expenses for Q2 2021 stood at $12.3 million, down from $12.5 million in the prior quarter.
• The five-year high for Other Accumulated Expenses was $41.2 million in Q2 2019, with the low at $10.9 million in Q2 2017.
• Historically, Other Accumulated Expenses has averaged $17.6 million across 5 years, with a median of $12.3 million in 2021.
• Annual changes were most pronounced in 2019 — Other Accumulated Expenses jumped 274.91% — and 2020, when it sank 69.7%.
• Resmed's Other Accumulated Expenses stood at $10.9 million in 2017, then rose by 0.93% to $11.0 million in 2018, then jumped by 274.91% to $41.2 million in 2019, then slumped by 69.7% to $12.5 million in 2020, then slipped by 1.77% to $12.3 million in 2021.
• The last three Other Accumulated Expenses figures came in at $12.3 million (Q2 2021), $12.5 million (Q2 2020), and $41.2 million (Q2 2019), per Business Quant data.